Application 076712
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TERCONAZOLE | TERCONAZOLE | CREAM;VAGINAL | 0.4% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076712-001 | TERCONAZOLE | TERCONAZOLE | 0.4% | CREAM / VAGINAL | AB | 2005-02-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076712-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076712-001 | TERCONAZOLE | 0.4% | CREAM / VAGINAL | AB | 2005-02-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076712-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terconazole | TERCONAZOLE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 10e84353-93d2-461d-8b79-e9294df047ae | 2026-01-28 | Warnings, Adverse reactions | 076712 ANDA076712 0168-0346 |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | e0a5e163-741f-4f5e-9d2e-b733f9879c99 | 2023-10-31 | Warnings, Adverse reactions | 076712 ANDA076712 50090-6266 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0346 | Terconazole | terconazole | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0346 | Terconazole | terconazole | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0346 | Terconazole | terconazole | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 0168-0346 | Terconazole | terconazole | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 50090-6266 | Terconazole | terconazole | A-S Medication Solutions | ANDA | Current |